Delivery Order SPE2DB22D2214-SPE2DB24FS3VM
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,119.93 firm fixed price delivery order is for the supply of Erythromycin 0.5% Eye Ointment 3.5GM to support military treatment programs and facilities. The award has a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,479.57 contract is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a performance period through April 30, 2024. The contract is a firm fixed-price agreement with no set-aside requirements. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC)...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, is for the supply of Erythromycin 0.5% eye ointment (3.5 gm) to the Defense Logistics Agency (DLA). The contract, valued at $6,481.58, is a delivery order issued under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for...
- This federal contract award, valued at $2,071.86, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566878522 - ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug...
- This federal contract award, valued at $2,153.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 0.5% erythromycin eye ointment, with a completion date of September 25, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,227.19, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,751.97 delivery order contract is for the supply of Erythromycin 0.5% Eye Ointment 3.5 GM, with a completion date of October 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment (3.5 grams) to the Defense Logistics Agency (DLA). The $8,320.47 firm fixed-price delivery order was awarded on August 18, 2022 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 19, 2022. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 31, 2025, which serves as the primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,639.88, is for the delivery of Erythromycin 0.5% eye ointment in 3.5 gram tubes. This is a Firm Fixed Price Delivery Order contract with a completion date of July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Erythromycin 0.5% eye ointment in 3.5 gram tubes, with a total ceiling value of $2,221.41. It is a firm fixed-price delivery order contract with a completion date of July 11, 2025. The contract is not set-aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS3VMDelivery Order
This federal contract award, valued at $1,298.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% Eye Ointment 3.5GM, a pharmaceutical product, with a performance period through March 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/5/24 |